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Hepatocellular carcinoma (HCC) is the most common primary liver tumor 
and represents the third-leading cause of cancer-related death in the world. 
The incidence of HCC continues to increase worldwide, with a unique 
geographic, age, and sex distribution.The present study is aimed to determine 
prevalence of hepatocellular carcinoma (HCC) in sub-urban Rawalpindi 
Pakistan and to evaluate the role of its associated risk factors. Blood sample 
collected and different biochemical blood test performed in this study. The 
study was conducted from August 2015 to july 2016. Blood samples 
collected and processed after serum separation.,Current result showed that 
people those with the age between 30-60 years are potentially at higher risk 
of getting HCC females are higher risk of getting HCC than the males (P<0). 
Clinico-pathological result showed that including higher value in HCC 
patients than the normal NON-HCC people. 
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INTRODUCTION 
 Liver malignancy, transcendently 
hepatocellular carcinoma(HCC), is the 
succeeding and 6th mainly deadly disease 
within both male as well as females, 
individually, and happened in around 
750,000 new patients and brought on 
700,000 demise in 2008 [1].Further 80% of 
the belongings happen in creating nations in 
the Asia-Pacific areas and sub-Saharan 
Africa, and China alone records for over half 
[2]. Geographic disseminations of sex, and 
period of HCC are mainly an aftereffect of 
the specific examples of these danger 
variables, with the dominant part of 
belongings the screech of hepatitis B and C 
virus contamination and intoxicating liver 
infection [3]. 
The quantity of instances of patients of HCC 
changes unmistakably in distinctive locales. 
The greatest rate of HCC was found in Asia-
pacific range (>20/100,000), while low 
recurrence was begin in Northern Europe 
and Northern America (<5/100,000) [4]. 
Lamentably, there is no accessibility of 
information populace based study which a 
genuine commonness and frequency rate of 
HCC could be learned. Numerous study 
which was behavior clinic based, and this 
information is comprised of case 
arrangement with little specimen sizes or 
they had a very select populace. Be that as it 
may, there has been a couple of tumor 
registries framework present in Pakistan. 
The Karachi Cancer Registry (KCR) was the 
first populace based malignancy registry, set 
up in 1995, by the Sindh Government, in 
specialized relationship with the Unit of 
Descriptive Epidemiology, International 
Agency for Research on Cancer (IARC) of 
the World Health Organization (WHO) [5]. 
 
MATERIALS AND METHODS 
 This study includes both negative 
and positive control bunches alongside the 
test gatherings. Sound people incorporate 
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the adverse control gatherings while patients 
with any liver illness involve the 
constructive control amass however the 
exploratory gathering constitutes the patients 
with analyzed HCC.Blood samples (2-3 ml) 
were collected from diagnosed patients of 
HCC along with the negative control that 
include healthy subjects. 
 The aspirated blood was shifted to 
silica gel tube for biochemical analysis. 
Blood were centrifuged for the separation of 
the sera. The serum was stored at -80 
o
C for 
further analysis.Biochemical profiling was 
performed. Blood would be continued for 
the liver capacity test, lipid profile and 
hematological files. All tests were 
performed utilizing industrially accessible 
reagent units. 
 
Liver compounds; Alanine Amino 
Transferase (ALT), Aspartate Amino 
Transferase (AST) and Bilirubin were 
assessed through obvious light 
spectrophotometer (UV 4000 
Spectrophotometer, O.R.I. Germany), 
absorbance at 340 nm. Serum albumin and 
also included in the present study serum 
cholesterol, triglycerides, high thickness 
lipids (HDL) and low thickness lipids 
(LDL).  
 After performing all the biochemical 
assays, statistical analysis was performed. 
Univariate analysis was applied on veriables 
including ALT, AST, TBL, TCOL, HDL, 
LDL. The HCC positive and HCC negative 
control groups were compared for each 
variables using t test. A p-value of < 0.05 
was considered to indicate statistical 
significance for t test. 
RESULTS AND DISCUSSION 
 In the present study the patients 
infected with HCC showed the significant 
elevation in ALT, AST, and TBL and 
TCOL, serum total protein and albumin, 
these are the suitable factors which cause 
liver damage. The role of liver enzyme is 
important in present study, Mean ALT is 
significantly (p<0.05) higher in patients as 
compared to normal controls and mean AST 
values were non singnificantly (p>0.05). 
Elevated aminotransferases levels act as 
indicators of liver cell injury [5 6] and are 
usually predominant in liver cirrhosis with 
increased ALT levels [7]. Being the 
biomarker for inflammation of liver, serum 
ALT level is a widely used clinical practice 
[8].  Total bilirubin is TBL/mg HCC and 
NON- HCCMean±S.D (2.93±75 versus 
1.11±0.46). Present results are accordance 
with previous studies which showed the 
elevated liver enzyme [9].High bilirubin 
level is normally connected with liver 
metastases and liver tumor association 
prompting hepatocellular carcinoma and 
liver cirrhosis by dynamic or non-dynamic 
HCV or HBV [10]. Bilirubin has been 
reported as marker of liver injury and to 
determine the proper dose of interferon in 
patients with different genotypes [11]. 
 Significant increase in LDL, HDL, 
TCOL and TG was observed in patients for 
HCC. It has been understood that disease 
with HCV infection prompts hepatic harm, 
which thus identifies with changes in 
adjustments of the lipid digestion system. As 
obvious from present study a reliable solid 
affiliation exists between intense HCV 
disease and low levels of aggregate 
cholesterol, TAG, LDL and HDL that 
expand the contamination determination[12 
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